Valneva
multivalent disease vaccine candidate only program in advanced clinical development today | Valneva
Company
Deck Type
IPO
Sector
Industry
Deck date
April 2021
Slide
10 of 41
Related slides by other companies
BioNTech
Results
August 2021
infectious diseases a long term growth pillar | BioNTech
BioNTech
Results
August 2022
pursuing multiple novel covid vaccine approaches to provide durable and high level protection against evolving variants | BioNTech
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights